Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease-Reference-Cited by-同舟云学术

Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease

Published:2019-02-11 Issue:9 Volume:27 Page:984-994
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Tiozzo Fasiolo Laura¹²,Manniello Michele Dario³,Bortolotti Fabrizio²,Buttini Francesca¹,Rossi Alessandra¹,Sonvico Fabio¹^ORCID,Colombo Paolo¹⁴,Valsami Georgia⁵,Colombo Gaia²^ORCID,Russo Paola³^ORCID

Affiliation:

1. Department of Food and Drug, University of Parma, Parma, Italy;

2. Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy;

3. Department of Pharmacy, University of Salerno, Fisciano (SA), Italy;

4. PlumeStars Srl, Parma, Italy;

5. Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2019.1574300

Reference53 articles.

1. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

2. Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target

3. Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs

4. Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel.;Neuroscience Applied;2024

2. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics;Journal of Pharmaceutical Investigation;2023-09

3. Injectable systems of chitosan in situ forming composite gel incorporating linezolid-loaded biodegradable nanoparticles for long-term treatment of bone infections;Drug Delivery and Translational Research;2023-08-04

4. Using Liposomal and Intranasal Drugs and Pioglitazone for the Treatment and Prevention of Alzheimer’s Disease (Review);Pharmaceutical Chemistry Journal;2023-04

5. Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique;European Journal of Pharmaceutics and Biopharmaceutics;2023-04